PGEN logo

Precigen (PGEN) EBITDA

Annual EBITDA

-$89.23 M
-$26.80 M-42.93%

31 December 2023

PGEN EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

-$23.29 M
+$35.59 M+60.45%

30 September 2024

PGEN Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

-$136.11 M
-$5.14 M-3.92%

30 September 2024

PGEN TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PGEN EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-42.9%-28.3%-76.2%
3 y3 years-31.3%-27.9%-58.0%
5 y5 years+74.8%+39.6%+53.6%

PGEN EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-42.9%at low-643.6%+60.5%-122.7%at low
5 y5 years-42.9%+74.8%-166.8%+60.5%-7277.2%+53.6%
alltimeall time-165.8%+74.8%-114.1%+87.8%-124.9%+61.6%

Precigen EBITDA History

DateAnnualQuarterlyTTM
Sept 2024
-
-$23.29 M(-60.4%)
-$136.11 M(+3.9%)
June 2024
-
-$58.88 M(+165.6%)
-$130.97 M(+44.5%)
Mar 2024
-
-$22.17 M(-30.2%)
-$90.64 M(+1.6%)
Dec 2023
-$89.23 M(+42.9%)
-$31.77 M(+75.0%)
-$89.23 M(+15.5%)
Sept 2023
-
-$18.15 M(-2.2%)
-$77.27 M(+24.1%)
June 2023
-
-$18.55 M(-10.6%)
-$62.25 M(-3.6%)
Mar 2023
-
-$20.75 M(+4.8%)
-$64.56 M(+3.4%)
Dec 2022
-$62.43 M(-20.4%)
-$19.81 M(+532.5%)
-$62.43 M(+2.1%)
Sept 2022
-
-$3.13 M(-85.0%)
-$61.13 M(-19.8%)
June 2022
-
-$20.86 M(+12.0%)
-$76.21 M(-2.5%)
Mar 2022
-
-$18.63 M(+0.6%)
-$78.20 M(+6.5%)
Dec 2021
-$78.45 M(+15.5%)
-$18.51 M(+1.6%)
-$73.41 M(-14.8%)
Sept 2021
-
-$18.22 M(-20.3%)
-$86.14 M(-0.7%)
June 2021
-
-$22.85 M(+65.1%)
-$86.76 M(+23.3%)
Mar 2021
-
-$13.83 M(-55.7%)
-$70.37 M(+3.6%)
Dec 2020
-$67.94 M(-1.3%)
-$31.25 M(+65.9%)
-$67.94 M(+3582.3%)
Sept 2020
-
-$18.83 M(+191.8%)
-$1.84 M(-91.5%)
June 2020
-
-$6.45 M(-43.4%)
-$21.58 M(-41.6%)
Mar 2020
-
-$11.40 M(-132.7%)
-$36.98 M(-45.3%)
Dec 2019
-$68.80 M(-80.6%)
$34.84 M(-190.3%)
-$67.60 M(-77.0%)
Sept 2019
-
-$38.57 M(+76.5%)
-$293.68 M(-7.0%)
June 2019
-
-$21.85 M(-48.0%)
-$315.88 M(-10.6%)
Mar 2019
-
-$42.03 M(-78.0%)
-$353.34 M(-0.3%)
Dec 2018
-$354.33 M(+659.7%)
-$191.23 M(+214.7%)
-$354.33 M(+156.6%)
Sept 2018
-
-$60.77 M(+2.4%)
-$138.07 M(+24.6%)
June 2018
-
-$59.31 M(+37.9%)
-$110.83 M(+72.3%)
Mar 2018
-
-$43.01 M(-271.9%)
-$64.32 M(+37.9%)
Dec 2017
-$46.64 M(-72.4%)
$25.02 M(-174.6%)
-$46.64 M(-57.7%)
Sept 2017
-
-$33.53 M(+161.9%)
-$110.14 M(+9.2%)
June 2017
-
-$12.80 M(-49.5%)
-$100.83 M(-23.8%)
Mar 2017
-
-$25.33 M(-34.2%)
-$132.36 M(-21.5%)
Dec 2016
-$168.72 M
-$38.48 M(+58.9%)
-$168.72 M(+7.1%)
Sept 2016
-
-$24.22 M(-45.4%)
-$157.53 M(-6.3%)
DateAnnualQuarterlyTTM
June 2016
-
-$44.33 M(-28.1%)
-$168.11 M(+5.0%)
Mar 2016
-
-$61.69 M(+126.0%)
-$160.17 M(+135.6%)
Dec 2015
-$67.99 M(-8.9%)
-$27.29 M(-21.6%)
-$67.99 M(+258.0%)
Sept 2015
-
-$34.80 M(-4.4%)
-$18.99 M(-45.3%)
June 2015
-
-$36.39 M(-219.4%)
-$34.73 M(-29.9%)
Mar 2015
-
$30.49 M(+40.5%)
-$49.55 M(-33.6%)
Dec 2014
-$74.64 M(+122.4%)
$21.71 M(-143.0%)
-$74.64 M(-30.6%)
Sept 2014
-
-$50.53 M(-1.3%)
-$107.51 M(+167.4%)
June 2014
-
-$51.21 M(-1048.5%)
-$40.21 M(-736.9%)
Mar 2014
-
$5.40 M(-148.4%)
$6.31 M(-118.8%)
Dec 2013
-$33.56 M(-54.5%)
-$11.16 M(-166.6%)
-$33.56 M(-34.6%)
Sept 2013
-
$16.76 M(-457.8%)
-$51.31 M(-40.7%)
June 2013
-
-$4.68 M(-86.4%)
-$86.48 M(-10.2%)
Mar 2013
-
-$34.48 M(+19.2%)
-$96.30 M(+30.4%)
Dec 2012
-$73.83 M(-8.6%)
-$28.91 M(+57.1%)
-$73.83 M(-194.3%)
Sept 2012
-
-$18.41 M(+27.0%)
$78.29 M(-69.2%)
June 2012
-
-$14.50 M(+20.7%)
$254.41 M(-41.4%)
Mar 2012
-
-$12.01 M(-109.8%)
$434.21 M(-16.5%)
Dec 2011
-$80.76 M
-
-
Dec 2011
-
$123.21 M(-21.9%)
$520.26 M(-4.8%)
Sept 2011
-
$157.71 M(-4.6%)
$546.56 M(+20.1%)
June 2011
-
$165.29 M(+123.3%)
$455.00 M(+29.5%)
Mar 2011
-
$74.04 M(-50.5%)
$351.35 M(-5.3%)
Dec 2010
-
$149.51 M(+126.0%)
$371.17 M(+0.6%)
Sept 2010
-
$66.15 M(+7.3%)
$368.79 M(-19.4%)
June 2010
-
$61.64 M(-34.3%)
$457.44 M(-13.1%)
Mar 2010
-
$93.86 M(-36.2%)
$526.69 M(+16.8%)
Dec 2009
-
$147.14 M(-5.0%)
$451.04 M(+36.6%)
Sept 2009
-
$154.80 M(+18.3%)
$330.11 M(+72.6%)
June 2009
-
$130.89 M(+618.8%)
$191.24 M(+216.9%)
Mar 2009
-
$18.21 M(-30.5%)
$60.35 M(+43.2%)
Dec 2008
-
$26.21 M(+64.5%)
$42.14 M(+164.5%)
Sept 2008
-
$15.93 M
$15.93 M

FAQ

  • What is Precigen annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Precigen?
  • What is Precigen annual EBITDA year-on-year change?
  • What is Precigen quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for Precigen?
  • What is Precigen quarterly EBITDA year-on-year change?
  • What is Precigen TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for Precigen?
  • What is Precigen TTM EBITDA year-on-year change?

What is Precigen annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of PGEN is -$89.23 M

What is the all time high annual EBITDA for Precigen?

Precigen all-time high annual earnings before interest, taxes, depreciation & amortization is -$33.56 M

What is Precigen annual EBITDA year-on-year change?

Over the past year, PGEN annual earnings before interest, taxes, depreciation & amortization has changed by -$26.80 M (-42.93%)

What is Precigen quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of PGEN is -$23.29 M

What is the all time high quarterly EBITDA for Precigen?

Precigen all-time high quarterly earnings before interest, taxes, depreciation & amortization is $165.29 M

What is Precigen quarterly EBITDA year-on-year change?

Over the past year, PGEN quarterly earnings before interest, taxes, depreciation & amortization has changed by -$5.14 M (-28.32%)

What is Precigen TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of PGEN is -$136.11 M

What is the all time high TTM EBITDA for Precigen?

Precigen all-time high TTM earnings before interest, taxes, depreciation & amortization is $546.56 M

What is Precigen TTM EBITDA year-on-year change?

Over the past year, PGEN TTM earnings before interest, taxes, depreciation & amortization has changed by -$58.84 M (-76.15%)